Send feedback

F9 p.Arg191His

c.572G>A · rs137852238 · VCV10585

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 10 submitters
AlphaMissense
likely benign
0.1576 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000447%, nfe)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
hemophilia B

ClinGen expert panel — Coagulation Factor Deficiency VCEP

Pathogenic for hemophilia B. Applied ACMG criteria (verbatim):

PP4_Moderate PM1_Strong PS4_VeryStrong PP3

Curation rationale (ClinGen, verbatim)

The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.1576likely benign ⚠ discordant with ClinVar
REVEL0.73pathogenic-leaning
SaProtLLR -6.99tolerated
⇒ REVEL calls this damaging; AlphaMissense and SaProt do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 4.6, phastCons 1
Regional constrainto/e 0.57unconstrained · MANE · 25 kb · p 2.3e-14 · regional, not allelic
Overall
CADD20.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000447% European (non-Finnish) · 4/894,893 alleles
Filtering AF 0.000105% ClinGen BA1/BS1 input FAF95, joint · FAF99 7.1e-05%
Overall 0.000331% 4/1,209,580 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
F9
Protein
p.Arg191His
Coding
c.572G>A
MANE Select
NM_000133
dbSNP
rs137852238
Type
single nucleotide variant
Location
chrX:139551113 (GRCh38)
Structure
AlphaFold pLDDT 80.45 · 57 PDB
Residue 191
a UniProt-annotated variant site (in hemb; moderate; albuquerque, cardiff-1); a UniProt-annotated variant site (in hemb; moderate; chapel-hill, chicago-2); a functional site (cleavage; by factor xia); a disulfide bond
Full F9 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hemophilia B — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: thrombophilia, X-linked, due to factor 9 defecthemophilia A

For Hemophilia B (Orphanet):

Inheritance
X-linked recessive
Onset
Childhood, Infancy, Neonatal
Prevalence
1-9 / 100 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/f9-p-arg191his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown